Clinical Trial Update: PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED) [Phase 4]

View source ↗

Summary

A completed Phase 4 trial evaluating the combination of pegylated interferon alfa-2b and ribavirin in treatment-naive Mexican patients with chronic hepatitis C …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: Schering-Plough | Conditions: Hepatitis C, Chronic | Phase 4 | Status: COMPLETED